Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease

NCT00532883 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped Enrollment has been terminated due to a slow rate of enrollment.

Conditions

Hemoglobin SC Disease

Interventions

DRUG: Hydroxyurea
DRUG: Magnesium Pidolate
OTHER: Placebo Pills and Placebo Liquid

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]